Jung Wan Park
- Infectious Diseases top 5%
- Modeling and Simulation top 2%
- Epidemiology
- Pulmonary and Respiratory Medicine
- Neurology
- Topics
- SARS-CoV-2 and COVID-19 Research (5 papers)COVID-19 Clinical Research Studies (5 papers)Antifungal resistance and susceptibility (3 papers)
- Partner nations
- South KoreaCanada
In The Last Decade
Jung Wan Park
17 papers receiving 510 citations
Peers
Comparison fields: 5 of 80
- Infectious Diseases 368
- Modeling and Simulation 113
- Epidemiology 94
- Pulmonary and Respiratory Medicine 53
- Neurology 48
Countries citing papers authored by Jung Wan Park
This map shows the geographic impact of Jung Wan Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung Wan Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung Wan Park more than expected).
Fields of papers citing papers by Jung Wan Park
This network shows the impact of papers produced by Jung Wan Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung Wan Park. The network helps show where Jung Wan Park may publish in the future.
Co-authorship network of co-authors of Jung Wan Park
This figure shows the co-authorship network connecting the top 25 collaborators of Jung Wan Park. A scholar is included among the top collaborators of Jung Wan Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung Wan Park. Jung Wan Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 18 | |
| 9 | 12 | |
| 10 | 35 | |
| 11 | 16 | |
| 12 | 10 | |
| 13 | 14 | |
| 14 | 17 | |
| 15 | 7 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 55 | |
| 19 | 1 | |
| 20 | 텍스트 리스트에서의 빈도분리 Knob의 효용성 검증 | 2 |
About Jung Wan Park
Jung Wan Park is a scholar working on Microbiology, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 21 papers that have together received 519 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Antifungal resistance and susceptibility (3 papers). The work is most often cited by research in Modeling and Simulation (113 citations), Infectious Diseases (368 citations) and Applied Microbiology and Biotechnology (28 citations). Jung Wan Park has collaborated with scholars based in South Korea and Canada. Frequent co-authors include Eun Jung Lee, Tae Hyong Kim, Eun Ju Choo, Se Yoon Park, Tark Kim, Seungjae Lee, Shinae Yu, Hyo‐Ju Son, Suyeon Park and Mark Loeb. Their work appears in journals such as Scientific Reports, Vaccine and JAMA Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.